MRNS Overview

Investor Alert: Bragar Eagel & Squire, P.C. is investigating potential claims against Marinus Pharmaceuticals, Inc. (MRNS) on behalf of long-term stockholders who may have suffered losses between March 17, 2021, and May 7, 2024, following a class action complaint filed on June 5, 2024.

Legal Concerns: The lawsuit alleges that Marinus's board of directors made misleading statements regarding the risks associated with clinical trials, which may have breached their fiduciary duties to the company and its shareholders.

Legal Investigation: Bragar Eagel & Squire, P.C. is investigating potential claims against Marinus Pharmaceuticals, Inc. (MRNS) on behalf of long-term stockholders due to a class action complaint alleging breaches of fiduciary duties by the company's board of directors during the period from March 17, 2021, to May 7, 2024.

Contact Information: Investors who suffered losses and wish to discuss their legal rights are encouraged to contact partners Brandon Walker or Marion Passmore at Bragar Eagel & Squire for more information and assistance.

Investigation of Companies: Halper Sadeh LLC is investigating Amplify Energy Corp., H&E Equipment Services, Inc., and Marinus Pharmaceuticals, Inc. for potential violations of federal securities laws and breaches of fiduciary duties to shareholders related to their recent transactions.

Shareholder Rights and Legal Support: The firm offers free consultations to shareholders regarding their rights and options, emphasizing that they operate on a contingent fee basis, meaning no upfront legal fees are required from clients.

Investigation of Companies: Halper Sadeh LLC is investigating potential violations of federal securities laws and breaches of fiduciary duties related to the sales and mergers of Marinus Pharmaceuticals, Regional Health Properties, SunLink Health Systems, and Innovid Corp.

Legal Support for Shareholders: The law firm offers free consultations to shareholders affected by these transactions, aiming to seek increased compensation and additional disclosures on their behalf.

Investigation of Companies: Halper Sadeh LLC is investigating Singular Genomics Systems, Marinus Pharmaceuticals, and Vacasa for potential violations of federal securities laws related to their recent sales at specified share prices.

Shareholder Rights: The law firm encourages shareholders from these companies to contact them for free consultations regarding their legal rights and options, with the possibility of seeking increased compensation or additional disclosures.

Investigation into Marinus Pharmaceuticals Sale: Former Louisiana Attorney General Charles C. Foti, Jr. and Kahn Swick & Foti, LLC are investigating the proposed sale of Marinus Pharmaceuticals to Immedica Pharma AB, where shareholders would receive $0.55 per share, to assess if this offer undervalues the company.

Legal Rights and Contact Information: KSF is inviting shareholders who believe the transaction undervalues Marinus or wish to discuss their legal rights to contact them without obligation, emphasizing the urgency due to the tender offer structure of the transaction.